Back to Search
Start Over
Dopamine D2 Receptor Occupancy Estimated From Plasma Concentrations of Four Different Antipsychotics and the Subjective Experience of Physical and Mental Well-Being in Schizophrenia
- Source :
- Journal of Clinical Psychopharmacology. 39:550-560
- Publication Year :
- 2019
- Publisher :
- Ovid Technologies (Wolters Kluwer Health), 2019.
-
Abstract
- Background Impaired subjective well-being in schizophrenia patients treated with antipsychotics has often been linked inter alia to the antidopaminergic effects of medication. Thus, it is important to capture the association between striatal dopamine D2 receptor occupancy (D2-RO) and global subjective well-being. We examined this association using data from our multicenter, randomized, double-blind Neuroleptic Strategy Study (NeSSy). Methods An innovative double randomization process was used for allocation of patients to the specific treatment groups. Plasma drug concentrations were measured after 6 and 24 weeks of treatment to obtain the estimated D2-RO (eD2-RO) relative to literature values. We made an exploratory analysis of associations between eD2-RO and subjective well-being scores. One hundred two blood samples from 69 patients were available for the analysis. Because of the lack of a satisfactory occupancy model for quetiapine, only haloperidol, flupentixol, and olanzapine treatment groups were pooled, whereas aripiprazole data were analyzed separately, because of its partial agonistic properties. Results In the pooled antagonist group, eD2-RO correlated negatively with the summarized well-being score. In a more detailed analysis, this association could be confirmed for all first-generation antipsychotic-treated patients, but not for the separate second-generation antipsychotic groups. In the aripiprazole group, higher eD2-RO was associated with impaired physical well-being, but had no association with mental well-being. Conclusions Our results suggest that high plasma levels and consequently high occupancy at D2 receptors are disadvantageous for subjective well-being, as distinct from the objective extrapyramidal side effects. To minimize patients' malaise, which disfavors adherence, implementation of therapeutic drug monitoring in the clinical routine may be useful.
- Subjects :
- Adult
Male
Olanzapine
medicine.medical_specialty
medicine.medical_treatment
Aripiprazole
Personal Satisfaction
Medication Adherence
law.invention
03 medical and health sciences
Sex Factors
0302 clinical medicine
Double-Blind Method
Randomized controlled trial
law
Internal medicine
medicine
Haloperidol
Humans
Pharmacology (medical)
Antipsychotic
Receptors, Dopamine D2
business.industry
Middle Aged
medicine.disease
3. Good health
030227 psychiatry
Flupentixol
Flupenthixol
Dopamine D2 Receptor Antagonists
Psychiatry and Mental health
Schizophrenia
Quality of Life
Quetiapine
Female
Schizophrenic Psychology
business
030217 neurology & neurosurgery
Antipsychotic Agents
medicine.drug
Subjects
Details
- ISSN :
- 1533712X and 02710749
- Volume :
- 39
- Database :
- OpenAIRE
- Journal :
- Journal of Clinical Psychopharmacology
- Accession number :
- edsair.doi.dedup.....e461c96769d5c7665f3c1f9fd506e70a
- Full Text :
- https://doi.org/10.1097/jcp.0000000000001131